SE8401748D0 - Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans - Google Patents

Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans

Info

Publication number
SE8401748D0
SE8401748D0 SE8401748A SE8401748A SE8401748D0 SE 8401748 D0 SE8401748 D0 SE 8401748D0 SE 8401748 A SE8401748 A SE 8401748A SE 8401748 A SE8401748 A SE 8401748A SE 8401748 D0 SE8401748 D0 SE 8401748D0
Authority
SE
Sweden
Prior art keywords
cream
graduate
release
active substance
antimycotic
Prior art date
Application number
SE8401748A
Other languages
English (en)
Other versions
SE8401748L (sv
Inventor
K Adams
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE8401748D0 publication Critical patent/SE8401748D0/sv
Publication of SE8401748L publication Critical patent/SE8401748L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8401748A 1983-03-30 1984-03-29 Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans SE8401748L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
SE8401748D0 true SE8401748D0 (sv) 1984-03-29
SE8401748L SE8401748L (sv) 1984-10-01

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401748A SE8401748L (sv) 1983-03-30 1984-03-29 Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans

Country Status (19)

Country Link
JP (1) JPS59184106A (sv)
KR (1) KR840008284A (sv)
AU (1) AU564956B2 (sv)
BE (1) BE899278A (sv)
CA (1) CA1212327A (sv)
CH (1) CH660126A5 (sv)
CY (1) CY1358A (sv)
DE (1) DE3311701A1 (sv)
ES (3) ES8503947A1 (sv)
FR (1) FR2543435B1 (sv)
GB (1) GB2137091B (sv)
GR (1) GR81485B (sv)
IT (1) IT1173761B (sv)
KE (1) KE3704A (sv)
LU (1) LU85271A1 (sv)
PH (1) PH20420A (sv)
PT (1) PT78313B (sv)
SE (1) SE8401748L (sv)
ZA (1) ZA842337B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
US5711954A (en) * 1992-06-08 1998-01-27 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
IT8420303A0 (it) 1984-03-29
PT78313A (en) 1984-04-01
PH20420A (en) 1987-01-05
BE899278A (fr) 1984-10-01
FR2543435B1 (fr) 1988-06-17
DE3311701A1 (de) 1984-10-04
CY1358A (en) 1987-08-07
ES530846A0 (es) 1985-04-16
GB8408067D0 (en) 1984-05-10
LU85271A1 (de) 1984-11-14
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
KR840008284A (ko) 1984-12-14
GB2137091A (en) 1984-10-03
GB2137091B (en) 1986-10-01
CH660126A5 (de) 1987-03-31
KE3704A (en) 1987-03-27
AU564956B2 (en) 1987-09-03
ES8601692A1 (es) 1985-11-16
ES539289A0 (es) 1985-11-16
FR2543435A1 (fr) 1984-10-05
SE8401748L (sv) 1984-10-01
IT1173761B (it) 1987-06-24
AU2623684A (en) 1984-10-04
CA1212327A (en) 1986-10-07
ES8601693A1 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
JPS59184106A (ja) 1984-10-19
GR81485B (sv) 1984-12-11
ES539290A0 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
MX9202638A (es) Esteres de metilo del acido 2-fenil-3-metoxiacrilico substituidos y composiciones fungicidas que los contienen.
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ES2042723T3 (es) Un procedimiento para preparar una composicion farmaceutica granular.
IT7848604A0 (it) Ossime derivate dall'acido 3-acetossimetil 7-ammino-tiazolil-acetammi do cefalosporanico procedimento per la loro produzione e composizioni farmaceutiche che le contengono come ingrediente attivo
GB938828A (en) Improvements in or relating to pharmaceutical capsules comprising radioactive materials
ATE2650T1 (de) Medikiertes tierfutter auf basis lebermehl und verfahren zu seiner herstellung.
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
IT1140529B (it) Composizioni da usarsi come cosmetici e procedimento per la preparazione dei loro ingredienti attivi
IT7947811A0 (it) Zilico sostituito racemico ovvero esteri di acido acetico sostituito otticamente attivo dotati di pro otticamente attivo e di alcool benprieta' insetticide procedimento per la loro produzione e composizioni insetticide che li contengono
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
SE8401748L (sv) Antimykotiskt medel i form av krem med hoggradig frigoring av verksam substans
IL56822A (en) Pentafluorobenzyl esters of substituted cyclopropanecarboxilic acids,their preparation and their use as insecticides and acaricides
SE8506072D0 (sv) Stabiliserad veteperoxidkomposition
JPS55133305A (en) Perfume controller
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
JPS5549313A (en) Vitamin pharmaceutical and its preparation
JPS5753401A (en) Hair nourishing agent for promoting hair growth
BE877050A (fr) Utilisation d'esters d'acides hydroxycarboxyliques aliphatiques en tant que desodorisants
IT8024165A0 (it) Esteri di acidi dialogenovinilciclopropancarbossili ci, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi e anche alcooli alfa-alogenoetinil-3-fenossi-benzilici.
SE8301565D0 (sv) Oljeloslig komposition innehallande fettloslig vitamin
JPS55133306A (en) Perfume controller
NO912890D0 (no) Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling.
SU365147A1 (ru) ) всесоюзная
AR229086A1 (es) Procedimiento para preparar esteres derivados del acido 2-(5,6-dihidro-4h-1,3-tiazin-2-il)-3-sustituido-propionico y procedimiento para preparar una composicion pesticida agricultural que contenga dichos esteres
JPS55133480A (en) Antioxidant